首页> 外文期刊>Gynecologic Oncology: An International Journal >Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types.
【24h】

Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types.

机译:感染艾滋病毒的女性更常感染非16和-18高危型HPV。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: To review and summarize evidence from clinical, translational and epidemiologic studies which have examined the clinically relevant aspects of HPV type prevalence and cervical dysplasia in HIV-infected women. METHODS: Relevant studies were identified through a MEDLINE search. References of identified reports were also used to identify additional published articles for review. RESULTS: HIV-infected women in different geographic regions (such as Zambia, Brazil, Rochester NY) appear to be infected with less prevalent types of HR-HPV as compared to the general population who, across all continents, are more commonly infected with types 16 and 18. Secondly, integration of HPV DNA into the host genome is no longer thought to be a necessary cause of malignant transformation of cervical cells. However, rate of integration appears to differ by the type of HPV. In fact, the types of HPV which appear to be more common in cervical dysplasia of HIV-infected women are the same types which are more likely to require integration for malignant transformation. Finally, HPV types found in HIV-infected women are relatively common and likely to persist. The most common among these types belong to the alpha-9 and -7 species which are the most carcinogenic species. CONCLUSION: Given that current vaccines target HR-HPV-16/18, the findings from the above mentioned studies may have important implications for the design of HPV vaccines that target the types of HPV associated with disease risk in HIV-infected women. HPV typing and assessment of the physical state (whether it is integrated or episomal) appear to be two valuable parameters for the prognostic evaluation of dysplastic lesions of the uterine cervix. This, however, has not yet been assessed in HIV-infected women. Recent data about the immune response in HPV/HIV co-infection may lead to understanding potential mechanisms for less virulent HPV causing malignant transformation in HIV-infected women.
机译:目的:回顾和总结来自临床,转化和流行病学研究的证据,这些研究检查了HIV感染女性的HPV类型患病率和宫颈不典型增生的临床相关方面。方法:通过MEDLINE搜索确定相关研究。所识别报告的参考文献也被用来识别其他已发表的文章以供审核。结果:与分布在各大洲的普通人群相比,不同地理区域(如赞比亚,巴西,纽约州罗切斯特)受艾滋病毒感染的妇女似乎感染的HR-HPV流行类型较少参见图16和18。其次,不再将HPV DNA整合入宿主基因组中成为宫颈细胞恶性转化的必要原因。但是,整合率似乎因HPV的类型而异。实际上,在感染HIV的女性子宫颈发育不良中更常见的HPV类型与更可能需要整合以进行恶性转化的相同类型。最后,在感染了HIV的女性中发现的HPV类型相对普遍并且可能持续存在。这些类型中最常见的是致癌性最强的α-9和-7种。结论:鉴于当前的疫苗针对HR-HPV-16 / 18,上述研究的发现可能对设计针对与HIV感染妇女的疾病风险相关的HPV类型的HPV疫苗的设计具有重要意义。 HPV分型和身体状态的评估(无论是整合的还是附加的)似乎是评估子宫颈增生性病变预后的两个重要参数。但是,尚未对感染艾滋病毒的妇女进行评估。有关HPV / HIV合并感染的免疫反应的最新数据可能会导致人们了解低毒性HPV可能导致HIV感染妇女发生恶性转化的潜在机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号